65.16

4.20% -2.86

After Hours: 66.46 1.30 +2.00%

Bright Minds Biosciences Inc (DRUG)

Overview News Price History Discussions Forecast Stock Split

Bright Minds Biosciences Inc stock is traded at $65.16, with a volume of 93,009. It is down -4.20% in the last 24 hours and down -15.76% over the past month. Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Previous Close:

$68.02

Open:

$67.84

24h Volume:

93,009

Relative Volume:

0.35

Market Cap:

$639.35M

Revenue:

Net Income/Loss:

$-19.80M

P/E Ratio:

-26.68

EPS:

-2.4426

Net Cash Flow:

$-14.56M

1W Performance:

-10.51%

1M Performance:

-15.76%

6M Performance:

-17.84%

1Y Performance:

+48.26%

1-Day Range:

$64.53

$69.06

1-Week Range:

$64.53

$73.33

52-Week Range:

$39.70

$123.75

Bright Minds Biosciences Inc Stock (DRUG) Company Profile

Name

Bright Minds Biosciences Inc

Sector

Healthcare (1074)

Industry

Biotechnology (600)

Phone

Address

Employee

Twitter

Next Earnings Date

2026-08-13

Latest SEC Filings

DRUG's Discussions on Twitter

Compare DRUG vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DRUG Bright Minds Biosciences Inc	65.16	770.84M	0	-19.80M	-14.56M	-2.4426
VRTX Vertex Pharmaceuticals Inc	546.12	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	827.72	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,033.15	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.55	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	210.02	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Bright Minds Biosciences Inc Stock (DRUG) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-13-26	Initiated	Jefferies	Buy
Sep-08-25	Initiated	BTIG Research	Buy
May-13-25	Initiated	TD Cowen	Buy
May-07-25	Initiated	Chardan Capital Markets	Buy
Jan-23-25	Initiated	Piper Sandler	Overweight
Jan-10-25	Initiated	Cantor Fitzgerald	Overweight
Jan-10-25	Initiated	H.C. Wainwright	Buy
Nov-26-24	Initiated	Robert W. Baird	Outperform

View All

Bright Minds Biosciences Inc Stock (DRUG) Latest News

Sep 05, 2026

Trading the Move, Not the Narrative: (DRUG) Edition - news.stocktradersdaily.com

Sep 05, 2026

Top 10 Best Biotech Companies In Canada 2026 - Nubia Magazine!

Sep 05, 2026

Sep 04, 2026

A biotech company will present at two healthcare conferences in September. - Stock Titan

Sep 04, 2026

Bright Minds Biosciences Stock Slides 4.82% as Biotech Volatility Bites: Is More Downside Pressure Ahead for CN:DRUG? - kalkine.ca

Sep 04, 2026

Bright Minds Biosciences Faces Fresh Pressure as Clinical Execution Risk Weighs on Sentiment - kalkine.ca

Sep 04, 2026

Sep 03, 2026

Bright Minds Biosciences (NASDAQ:DRUG) Stock Price Down 5.2%Time to Sell? - MarketBeat

Sep 03, 2026

Braidwell LP Decreases Stock Holdings in Bright Minds Biosciences Inc. $DRUG - MarketBeat

Sep 03, 2026

Sep 01, 2026

Bright Minds Biosciences Stock Falls 3.06%: CN:DRUG Faces Correction Pressure as Clinical and Valuation Risks Test Sentiment - kalkine.ca

Sep 01, 2026

Aug 31, 2026